Safety and Efficacy of Mesenchymal Stromal Cell Therapy for Multi-Drug-Resistant Acute and Late-Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Scientists presented a multicenter study on the safety and efficacy of MSC therapy for patients with steroid-refractory late steroid-refractory acute graft versus host disease (aGvHD) in comparison to those with aGvHD.